Drug Shortage Report for SOFRACORT

Last updated on 2022-08-16 History
Report ID 159765
Drug Identification Number 02224623
Brand name SOFRACORT
Common or Proper name Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) GRAMICIDIN DEXAMETHASONE FRAMYCETIN SULFATE
Strength(s) 0.05MG 0.5MG 5MG
Dosage form(s) DROPS
Route of administration OTIC OPHTHALMIC OTIC OPHTHALMIC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 8 mL bottle
ATC code S03CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-04-29
Estimated end date 2022-09-07
Actual end date 2022-08-15
Shortage status Resolved
Updated date 2022-08-16
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-08-16 English Compare
v12 2022-08-15 French Compare
v11 2022-08-15 English Compare
v10 2022-06-09 French Compare
v9 2022-06-09 English Compare
v8 2022-05-03 French Compare
v7 2022-05-03 English Compare
v6 2022-05-03 English Compare
v5 2022-04-30 English Compare
v4 2022-04-29 French Compare
v3 2022-04-29 English Compare
v2 2022-04-29 French Compare
v1 2022-04-29 English Compare

Showing 1 to 13 of 13